Probiotics Infant Gas Relief: What The Evidence Actually Says
- 01. Probiotics infant gas relief: what the evidence actually says
- 02. How probiotics may affect infant gas
- 03. Key clinical trials and meta-analyses
- 04. Recent meta-analytic evidence
- 05. Subgroups where probiotics may help more
- 06. Strains, dosing, and real-world product claims
- 07. Risks, safety, and contraindications
- 08. Alternatives and adjunct strategies for infant gas
- 09. Timeline of key evidence milestones
- 10. Practical guidance for parents
- 11. Illustrative evidence summary table
- 12. Structured recommendations for parents
- 13. Step-by-step decision checklist
Probiotics infant gas relief: what the evidence actually says
Probiotics, particularly Lactobacillus reuteri DSM 17938, can modestly reduce crying and fussiness in some exclusively breastfed infants with colic, but the evidence for direct, reliable infant gas relief is more limited and inconsistent. Clinical trials report average crying-time reductions of about 30-70 minutes per day in breastfed babies, with weaker or no effects in formula-fed infants or those born by caesarean section. Safety data from randomized controlled trials suggest that a single-strain probiotic at doses around $$10^8$$ colony-forming units daily is generally well tolerated, though routine use in healthy term infants is not yet universally recommended by major pediatric societies.
How probiotics may affect infant gas
Theoretically, probiotics may ease infant gas by altering the gut microbiota composition to favor bacteria that produce less gas or ferment carbohydrates more efficiently. Certain strains, especially Lactobacillus species, can compete with gas-producing bacteria in the colon and may reduce lactose malabsorption, which can indirectly lessen bloating and abdominal discomfort in infants. In preclinical and small human studies, probiotic colonization has been linked to changes in inflammatory markers and visceral sensitivity, which may lower the perception of gas-related pain in infants.
.jpg)
However, a direct, mechanistic "gas-busting" effect is not strongly proven in infants; most clinical endpoints in trials are measured as crying time or colic severity, not objective gas volume or frequency. Conflicting trial results and heterogeneous study designs mean that any benefit for gas is likely strain-specific, dose-dependent, and confined to particular subgroups of infants.
Key clinical trials and meta-analyses
A 2012 Italian trial of Lactobacillus reuteri DSM 17938 in 90 exclusively breastfed infants with colic found that the probiotic group had significantly lower daily crying times at days 7, 14, 21, and 28 compared with placebo, with a relative risk of being a "responder" up to 4.3 at day 14. By day 21, about twice as many infants in the probiotic arm achieved a 50% reduction in crying, and parents reported better family quality of life and lower perceived colic severity.
In contrast, a 2014 Australian randomized trial (BMJ, 2014) of L. reuteri in 167 infants with colic found no difference in crying, fussing, sleep, or parental quality of life compared with placebo, regardless of feeding type. This trial highlighted that findings may depend on population characteristics, baseline crying patterns, and delivery method (breast vs formula), underscoring the limits of generalizing probiotic efficacy across all infants.
Recent meta-analytic evidence
A 2024 systematic review and meta-analysis of randomized controlled trials on probiotics for infantile colic pooled data for infants under 3 months and found that probiotics reduced daily crying time by an average of about 51 minutes (p = 0.001). Subgroup analyses suggested stronger effects for exclusively breastfed infants (roughly 74 fewer minutes of crying per day) and for the L. reuteri DSM 17938 strain, while effects were smaller or non-significant in formula-fed and caesarean-born infants.
The review also noted that most trials used single-strain probiotics at doses around $$10^8$$ CFU per day, with no major safety signals over short-term use (typically 21-28 days). However, the authors emphasized that long-term safety data, optimal dosing, and strain selection remain uncertain, and that evidence for symptom-specific relief such as gas or bloating is inferred from global colic scores rather than direct measurements.
Subgroups where probiotics may help more
Available data suggest that probiotics are most likely to reduce crying and probably associated gas in exclusively breastfed infants with colic. A 2014 meta-analysis of raw data from trials in Melbourne, Italy, Poland, and Canada reported that among breastfed babies, the probiotic group was about twice as likely to experience a 50% reduction in crying by day 21 compared with placebo.
By contrast, evidence for formula-fed infants and those born by caesarean section is sparse and inconsistent; some trials show little to no benefit, and systematic reviews flag these subgroups as areas needing further study. Clinicians often interpret this as a conditional recommendation: probiotics may be considered for healthy, breastfed infants with severe colic, but not as a first-line solution for gas in all infants.
Strains, dosing, and real-world product claims
The bulk of positive evidence centers on Lactobacillus reuteri DSM 17938, administered at about $$10^8$$ CFU once daily, usually for 3-4 weeks. Other strains, including some Bifidobacterium species, have been tested in smaller trials, but meta-analyses indicate that effect sizes are more modest and less consistent than for DSM 17938.
Commercial products often market broader "gas relief" or "colic relief" claims that go beyond the data; for example, many infant probiotic drops and powders list "reduces crying" and "helps gas" without specifying strain, dose, or target population. Parents should, therefore, check the active strain and look for independent clinical trial data or systematic reviews that match their infant's feeding pattern before assuming a product will reliably ease gas-related discomfort.
Risks, safety, and contraindications
In randomized trials to date, short-term use of L. reuteri DSM 17938 in healthy term infants has not been linked to serious adverse events, with no difference in infection rates or severe gastrointestinal outcomes compared with placebo. Minor side effects, such as changes in stool frequency or mild abdominal rumbling, are occasionally reported but are usually transient and not clinically significant.
However, probiotics are not risk-free for all infants; there have been rare case reports of probiotic-associated infections in preterm or immunocompromised infants, which is why major pediatric organizations caution against routine probiotic use in these high-risk groups without medical supervision. Current guidelines generally recommend reserving probiotics for otherwise healthy term infants with persistent colic after safer measures (positioning, feeding adjustments, and parental support) have been tried.
Alternatives and adjunct strategies for infant gas
Before or alongside probiotics, pediatricians often recommend non-pharmacologic strategies that may reduce gas and crying in infants. These include proper feeding techniques (upright positioning, paced bottle-feeding, burping), ensuring an appropriate nipple flow to minimize air swallowing, and, in some cases, modifying the mother's diet (for example, a dairy-free trial) when sensitive formula changes are being considered.
Over-the-counter options such as simethicone drops have been tested head-to-head against L. reuteri in small trials, with some showing superior effects for the probiotic and others finding no difference, suggesting that simethicone's benefit is modest if present. Parents should discuss any supplement or medication with a pediatrician, especially if the infant has feeding difficulties, poor weight gain, or signs of allergy or reflux.
Timeline of key evidence milestones
An early 2011 Italian double-blind trial of L. reuteri DSM 17938 in colicky infants reported that median crying time fell from about 370 minutes per day at baseline to 35 minutes per day by day 21 in the probiotic group, versus 90 minutes in placebo, although the placebo group also improved. This study helped establish probiotic efficacy in colic and prompted a wave of follow-up trials and meta-analyses.
By 2014, a large Australian trial published in the British Medical Journal concluded that the same L. reuteri strain did not reduce crying or fussing in a mixed breast- and formula-fed cohort, highlighting the importance of context and population selection. The 2024 meta-analysis then synthesized these and later trials, providing updated estimates of crying-time reduction and clarifying subgroup effects, which now underpin much of current clinical guidance on probiotics for infantile colic.
Practical guidance for parents
For parents considering probiotics for infant gas relief, the evidence supports a cautious, individualized approach rather than routine use. A practical sequence might include: ruling out medical causes (allergy, reflux, infection), optimizing feeding and positioning, and then, if colic persists beyond about 2-3 weeks, discussing a time-limited trial of a well-studied probiotic strain with a pediatrician.
If a trial is started, parents should: choose a product specifying L. reuteri DSM 17938 or another strain with published trial data, follow the labeled dose (typically about $$10^8$$ CFU per day), and monitor for both symptom changes and any new issues (rashes, diarrhea, or feeding problems) over at least 2-3 weeks. If there is no clear improvement after 3 weeks, or if concerns arise, discontinuing the probiotic and reassessing with a clinician is prudent.
Illustrative evidence summary table
| Study or meta-analysis | Population | Probiotic used | Key outcome (crying time) | Infant gas implications |
|---|---|---|---|---|
| Italian RCT (2012) | 90 exclusively breastfed colicky infants | L. reuteri DSM 17938, 108 CFU/day | Large reduction (from ~370 to 35 min/day by day 21 vs 90 min in placebo) | Indirectly suggests possible gas-related relief if colic improves |
| Australian RCT (2014) | 167 mixed breast/ formula-fed colicky infants | L. reuteri DSM 17938 | No significant difference in crying or fussing vs placebo | Questions generalizability of gas benefit across all feeding types |
| 2024 meta-analysis | Infants <3 months with colic (multiple RCTs) | Variety of probiotics, mainly L. reuteri DSM 17938 | Mean crying-time reduction ~51 min/day; strongest in breastfed infants | Gas relief inferred, not directly measured; likely most relevant for exclusively breastfed infants |
Structured recommendations for parents
- Consult a pediatrician before starting any probiotic supplement for an infant, especially if the baby is premature, has a medical condition, or shows feeding or growth issues.
- Use a probiotic product with a clearly identified strain such as Lactobacillus reuteri DSM 17938 and a dose in the range of about $$10^8$$ CFU per day, as used in clinical trials.
- Limit the trial period to 2-4 weeks and monitor for changes in crying, feeding, stooling, and any new symptoms; discontinue if no improvement or if adverse effects occur.
- Combine probiotic use with non-drug strategies such as proper feeding technique, burping, and gentle abdominal massage, which may further reduce gas and discomfort.
- Be skeptical of marketing claims such as "instant gas relief" or "guaranteed colic cure"; current evidence supports only modest, context-dependent benefits for some infants.
Step-by-step decision checklist
- Confirm the infant is otherwise healthy, with normal weight gain and no red-flag signs (fever, bloody stools, severe reflux, or allergy) that warrant urgent evaluation.
- Optimize feeding practices: ensure proper latch or bottle position, appropriate nipple flow, frequent burping, and, if breastfeeding, consider a short-term dietary trial (for example, dairy-free) if advised by a pediatrician.
- Track crying duration and timing for several days to establish a baseline; many infants show spontaneous improvement by 3-4 months even without intervention.
- Discuss a time-limited probiotic trial with a pediatrician, focusing on a strain with published trial data such as L. reuteri DSM 17938 and agreeing on a clear duration and stop rules.
- After 2-3 weeks, reassess: if crying has decreased by roughly half or the infant seems more comfortable, the probiotic may be helping; if not, tapering off and revisiting non-probiotic strategies is reasonable.
Overall, the evidence indicates that specific probiotics for infant colic can modestly reduce crying in some infants, which may translate to less gas-related discomfort, but they are not a guaranteed gas-relief solution and should be used thoughtfully within a broader management plan.
Key concerns and solutions for Probiotics Infant Gas Relief What The Evidence Actually Says
Are probiotics proven to relieve infant gas?
Probiotics are not yet proven to directly relieve infant gas in the way commonly advertised; clinical trials mainly measure crying time and colic severity, not gas volume or flatus. Some infants may experience less gas-associated discomfort if crying and colic improve, but this effect is indirect and likely limited to specific Lactobacillus strains and subgroups of infants.
Which probiotic strain has the best evidence for infant colic?
The strain with the most consistent evidence for reducing crying in infant colic is Lactobacillus reuteri DSM 17938, typically dosed at about $$10^8$$ colony-forming units once daily. Meta-analyses show that this strain produces greater average reductions in crying time than other single-strain formulations, especially in exclusively breastfed infants.
How long does it take for probiotics to work in infants?
Clinical trials suggest that it may take about 7-14 days to see a detectable reduction in crying and likely associated gas-related discomfort in responsive infants. Effects tend to plateau around 3 weeks, so clinicians often suggest evaluating the probiotic after 2-3 weeks of daily use before deciding whether to continue.
Are probiotics safe for healthy newborns?
Short-term use of L. reuteri DSM 17938 in healthy term infants appears safe in randomized trials, with no excess of serious adverse events compared with placebo. However, pediatric societies still consider probiotics as a targeted option rather than a universal supplement, and they are generally avoided in preterm or immunocompromised infants due to rare infection risks.
Do probiotics work for formula-fed babies' gas?
Current evidence for formula-fed infants is less convincing; several trials and a 2024 meta-analysis show smaller or non-significant reductions in crying and uncertain benefits for gas-related symptoms in this group. Parents of formula-fed babies should not assume that probiotics will reliably ease gas and should instead prioritize feeding technique, formula selection (if medically indicated), and professional evaluation of persistent symptoms.
What should parents look for on infant probiotic labels?
Parents should look for a clearly labeled strain name (for example, Lactobacillus reuteri DSM 17938), the CFU count per dose, and ideally a reference to randomized trials or independent reviews. Labels that emphasize broad "gas relief" or "colic relief" without specifying strain or population should be treated with caution, and dosing should follow product instructions or pediatrician advice.